General Discussion 167 7 References 1. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in Man: Implications for Health and Disease. Physiol Rev. 2015;95(1):1-46. doi:10.1152/physrev.00012.2014 2. Ralston MA, Murnane MR, Kelley RE, Altschuld RA, Unverferth D V. , Leier C V. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation. 1989;80:573-580. doi:10.1161/01.CIR.80.3.573 3. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48(7):927-940. 4. Del Gobbo LC, Imamura F,Wu JHY,deOliveiraOttoMC,Chiuve SE,MozaffarianD.Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98(1):160-173. doi:10.3945/ajcn.112.053132 5. Hruby A, O’Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. JACC Cardiovasc Imaging. 2014;7(1):59-69. doi:10.1016/j.jcmg.2013.10.006 6. Fang X,Wang K, Han D, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016;14(1):210. doi:10.1186/s12916-016-0742-z 7. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004;109(25 Suppl 1):IV31-46. doi:10.1161/01. CIR.0000133442.99186.39 8. Lyle AN, Raaz U. Killing Me Un-softly: Causes and Mechanisms of Arterial Stiffness Recent Highlights of ATVB: Early Career Committee Contribution. Arterioscler Thromb Vasc Biol. 2017. 9. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of Obesity Are Associated With Vascular Stiffness in Young and Older Adults. Hypertension. 2003;42(4):468473. doi:10.1161/01.HYP.0000090360.78539.CD 10. Joris PJ, Plat J, Bakker SJ, Mensink RP. Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebocontrolled intervention trial. Am J Clin Nutr.2016;103(5):1260-1266.doi:10.3945/ajcn.116.131466 11. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294(1-2):1-26. 12. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993. doi:10.1007/BF00401149 13. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and Cardiovascular Disease. Circulation. 1999;100(10):1134-1146. doi:10.1161/01.CIR.100.10.1134 14. Pham P-CT, Pham P-MT, Pham S V, Miller JM, Pham P-TT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007;2(2):366-373. doi:10.2215/CJN.02960906 15. Gommers LMM, Hoenderop JGJ, Bindels RJM, de Baaij JHF. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65(1):3-13. doi:10.2337/db15-1028 16. McNair P, Christiansen C, Transbøl I. Effect of menopause and estrogen substitutional therapy on magnesium metabolism. Miner Electrolyte Metab. 1984;10(2):84-87. 17. Groenestege WMT, Hoenderop JG, Van Den Heuvel L, Knoers N, Bindels RJ. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol. 2006. doi:10.1681/ASN.2005070700
RkJQdWJsaXNoZXIy MTk4NDMw